17860-28-5 Usage
Carboxylic acid derivative
It is a compound derived from a carboxylic acid by replacing the hydroxyl group (-OH) with another functional group.
Cyclopentane ring
The compound contains a five-carbon ring structure, which is characteristic of cycloalkanes.
Methoxy functional group
A methoxy group (-OCH3) is attached to the carbon in position 1, giving the compound its unique properties and reactivity.
Position 1
The methoxy group is attached to the first carbon atom in the cyclopentane ring, influencing the compound's structure and properties.
Organic synthesis
1-methoxycyclopentanecarboxylic acid is used as a building block or intermediate in the synthesis of more complex organic molecules.
Pharmaceutical research
Due to its unique structure and potential biological activity, the compound is used in the development of new drugs.
Material science applications
1-methoxycyclopentanecarboxylic acid may have potential uses in the development of new materials with specific properties.
Agrochemical applications
The compound may also be used in the field of agrochemicals, potentially contributing to the development of new pesticides, herbicides, or fertilizers.
Check Digit Verification of cas no
The CAS Registry Mumber 17860-28-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,8,6 and 0 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 17860-28:
(7*1)+(6*7)+(5*8)+(4*6)+(3*0)+(2*2)+(1*8)=125
125 % 10 = 5
So 17860-28-5 is a valid CAS Registry Number.
17860-28-5Relevant academic research and scientific papers
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
-
, (2014/09/29)
Described are compounds of Formula 1 which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
-
, (2014/09/30)
Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.
4-PHENYL-1,3-THIAZOLES AND 4-PHENYL-1,3-OXAZOLES DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS
-
Page/Page column 21, (2011/04/18)
The present invention relates to new 4-phenyl-1,3-azole derivatives having the general formula (I) wherein R1, R2, R3, R4, X, A, B, and n are variable, in a racemic form, an enantiomeric form or any combinations thereof. These compounds exhibit affinity f
